These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 5849594)

  • 1. Selective inhibition of growth and respiration of melanomas by tyrosinase inhibitors.
    Demopoulos HB; Gerving MA; Bagdoyan H
    J Natl Cancer Inst; 1965 Nov; 35(5):823-7. PubMed ID: 5849594
    [No Abstract]   [Full Text] [Related]  

  • 2. Tyrosinase inhibitor in Fortner's amelanotic and melanotic malignant melanoma.
    Satoh GJ; Mishima Y
    J Invest Dermatol; 1967 Apr; 48(4):301-3. PubMed ID: 6067129
    [No Abstract]   [Full Text] [Related]  

  • 3. COMPARISON OF ULTRASTUCTURE OF B-16 AND S-91 MOUSE MELANOMAS, AND CORRELATION WITH GROWTH PATTERNS.
    DEMOPOULOS HB; KASUGA T; CHANNING AA; BAGDOYAN H
    Lab Invest; 1965 Jan; 14():108-21. PubMed ID: 14258099
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular localization of tyrosinase and site of melanin formation in melanocyte.
    Seiji M; Iwashita S
    J Invest Dermatol; 1965 Nov; 45(5):305-14. PubMed ID: 5847300
    [No Abstract]   [Full Text] [Related]  

  • 5. Light-induced alterations in melanoma-related free radicals, and the consequences on respiration and growth.
    Demopoulos HB; Landgraf W; Duke PS; Tai H
    Lab Invest; 1966 Nov; 15(11):1652-8. PubMed ID: 4288918
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibition of respiration of pigmented S91 mouse melanomas by phenyl lactate, and the possibly related effects on growth.
    DEMOPOULOS HB; KALEY G
    J Natl Cancer Inst; 1963 Mar; 30():611-33. PubMed ID: 14026922
    [No Abstract]   [Full Text] [Related]  

  • 7. Tyrosinase inhibition: its role in suntanning and in albinism.
    Chian LT; Wilgram GF
    Science; 1967 Jan; 155(3759):198-200. PubMed ID: 6015525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and histochemical analyses of tyrosinase activity in melanoma and related lesions.
    CHANG JP; RUSSELL WO; STEHLIN JS; SMITH JL
    Ann N Y Acad Sci; 1963 Feb; 100():951-64. PubMed ID: 14020054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the effect of progesterone on the tyrosinase activity of melanoma S 91 in mice].
    Delacrétaz J
    Dermatologica; 1966; 132(2):89-91. PubMed ID: 5955352
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation and characterization of multiple forms of tyrosinase from mouse melanoma.
    Burnett JB; Seiler H; Brown IV
    Cancer Res; 1967 May; 27(5):880-9. PubMed ID: 4960889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on tyrosinase activity in experimental melanoma S 91 in mice and its variations on the effect of estradiol].
    Delacrétaz J; Lerch P
    Oncologia; 1965; 19(2):118-26. PubMed ID: 5862114
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinesterase and tyrosinase activity in malignant melanoma.
    Mishima Y
    Cancer; 1966 May; 19(5):665-73. PubMed ID: 4160261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent information on malignant melanomas].
    Mikol C
    Presse Med (1893); 1967 Apr; 75(21):1056. PubMed ID: 6024355
    [No Abstract]   [Full Text] [Related]  

  • 14. A sensitive fluorometric assay method for mammalian tyrosinase.
    Adachi K; Halprin KM
    Biochem Biophys Res Commun; 1967 Jan; 26(2):242-6. PubMed ID: 6030270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Examination of serum tyrosinase-DOPA oxidase with the aid of the hydroquinone-p-benzoquinone system in hepatic melansarcoma].
    Zălaru MC
    Med Interna (Bucur); 1966 Oct; 18(10):1245-9. PubMed ID: 5978452
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458.
    Hannig G; Lazarus DD; Bernier SG; Karp RM; Lorusso J; Qiu D; Labenski MT; Wakefield JD; Thompson CD; Westlin WF
    Int J Oncol; 2006 Apr; 28(4):955-63. PubMed ID: 16525646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.